SAN FRANCISCO, CA—Deepak Srivastava, MD, the Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Center for Stem Cell Biology and Medicine, has been elected to the National Academy of Sciences’ Institute of Medicine (IOM).
SAN FRANCISCO, CA—The power of regenerative medicine appears to have turned science fiction into scientific reality—by allowing scientists to transform skin cells into cells that closely resemble beating heart cells.
SAN FRANCISCO, CA—A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
SAN FRANCISCO, CA—What does it mean to be human? According to scientists the key lies, ultimately, in the billions of lines of genetic code that comprise the human genome. The problem, however, has been deciphering that code.
SAN FRANCISCO, CA—In the aftermath of a heart attack, cells within the region most affected shut down. They stop beating. And they become entombed in scar tissue.
SAN FRANCISCO, CA and COLLEGE STATION, TX—An enzyme is a tiny, well-oiled machine. A class of proteins that are made up of multiple, interlocking molecular components, enzymes perform a variety of tasks inside each cell.
SAN FRANCISCO, CA—The ability to form blood vessels is one of evolution’s crowning achievements, and something that separates vertebrates (animals with a backbone) from the rest of the animal kingdom.
SAN FRANCISCO, CA—Gladstone Institutes’ Senior Investigator Shinya Yamanaka, MD, PhD, is one of 11 medical researchers to win a new, high-profile $3 million award from a group of high-tech sponsors, including the founders of Facebook and Google.
Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that, like embryonic stem cells, are capable of developing into any cell in the human body.
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.